Table 5.

Treatment-emergent adverse reaction in patients with secondary TMA (n = 27)

	Adverse reaction	Serious adverse reaction
	Number of cases (/person-year)	Number of cases (/person-year)
Total exposure time (patient-years)	4.49
Total number of manifestations	11 (2.45)	8 (1.78)
Cytomegalovirus infection	1 (0.22)	1 (0.22)
Interstitial lung disease	1 (0.22)	1 (0.22)
Death	1 (0.22)	1 (0.22)
Ventricular flutter	1 (0.22)	1 (0.22)
Multiple organ dysfunction syndrome	1 (0.22)	1 (0.22)
Pneumonia	1 (0.22)	1 (0.22)
Pulmonary mycosis	1 (0.22)	1 (0.22)
Alveolar hemorrhage	1 (0.22)	1 (0.22)
Hypoalbuminemia	1 (0.22)	0 (0.00)
Insomnia	1 (0.22)	0 (0.00)
Delirium	1 (0.22)	0 (0.00)